Michael Floyd - Chief Operating Officer at Processa Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Issuer Symbol
PCSA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Floyd since 30 Dec 2024

Holdings reported by Michael Floyd for Processa Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 440,328 $1,080,389 $2.45 01 Jan 2023 Direct Common Stock
Common Stock 89,794 $26,938 $0.3 09 Feb 2023 by Elion Oncology, Inc.
Common Stock 82,267 $24,680 $0.3 09 Feb 2023 Direct

Transactions reported by Michael Floyd for Processa Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.